SCHEMBL16655005

SCHEMBL16655005

CN(C)C/C=C/CNc1ccc(C(=O)N[C@@H]2C[C@H](Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)CN(C)C2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK7 P50613 19/20 0.70
▸ CCNH P51946 15/20 0.70
▸ CCNK O75909 13/20 0.70
▸ CDK9 P50750 13/20 0.70
▸ CDK12 Q9NYV4 13/20 0.70
▸ CCNT1 O60563 12/20 0.70
▸ MNAT1 P51948 9/20 0.70
▸ CDK13 Q14004 11/20 0.62
▸ CDK2 P24941 10/20 0.62
▸ CCNA2 P20248 9/20 0.62
▸ CDK3 Q00526 1/20 0.60
▸ RPS6KA3 P51812 1/20 0.57
▸ MAPK8 P45983 2/20 0.55
▸ MAPK9 P45984 2/20 0.55
▸ CDK1 P06493 1/20 0.55
▸ CCNB1 P14635 1/20 0.55
▸ CDK5 Q00535 1/20 0.55
▸ CDK5R1 Q15078 1/20 0.55
▸ MAP3K11 Q16584 1/20 0.55
▸ JUN P05412 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16655055 1.00 CDK7 (0.70) CDK7CCNHCCNKCDK9CDK12
SCHEMBL18047375 0.92 CDK7 (0.83) CDK7CCNHCCNKCDK9CDK12
SCHEMBL16665765 0.92 CDK7 (0.83) CDK7CCNHCCNKCDK9CDK12
SCHEMBL21397354 0.92 CDK7 (0.83) CDK7CCNHCCNKCDK9CDK12
SCHEMBL16665764 0.92 CDK7 (0.83) CDK7CCNHCCNKCDK9CDK12
SCHEMBL18047381 0.92 CDK7 (0.83) CDK7CCNHCCNKCDK9CDK12
SCHEMBL18047419 0.92 CDK7 (0.83) CDK7CCNHCCNKCDK9CDK12
SCHEMBL16665649 0.92 CDK7 (0.83) CDK7CCNHCCNKCDK9CDK12
SCHEMBL16656090 0.91 CDK7 (0.84) CDK7CCNHCCNKCDK9CDK12
SCHEMBL16655054 0.87 CCNK (0.65) CDK7CCNHCCNKCDK9CDK12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3057954-A2 HETEROMAROMATIC COMPOUNDS USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES Syros Pharmaceuticals, Inc. (US) 2016-08-24 — — EP disclosed
WO-2015058163-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) SYROS PHARMACEUTICALS, INC. (US) 2015-04-23 — — WO disclosed
Send feedback